Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by gump132on Jun 21, 2018 1:03pm
88 Views
Post# 28206713

RE:RE:Hey Mike

RE:RE:Hey MikeChris asked him a few times and Brad answered that the financials for Q2 will "100% have revenue numbers". So that means they must have had at least some sales by the time they did the interview. I am sure they are pushing to get as much revenue in June before the end of Q2 so their first real earnings report looks good. I just hope Brad was underpromising this time but he normally overpromises.

Q2 might end up being less than amazing based on Brad's track record and optimism with timelines, but I'm patient. I can wait until Q3 and Q4 earnings to get a sense of the value of the company.
Bullboard Posts